Teva Pharmaceutical Industries | TEVA - Net Income

Stock Price
10,600.00
Daily Change
90.00 0.86%
Monthly
6.96%
Yearly
78.30%
Q1 Forecast
10,423.12

Teva Pharmaceutical Industries reported $480M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Aspen Pharmacare ZAR -3.47B 5.86B Jun/2025
Cipla INR 6.76B 6.75B Dec/2025
Dr.Reddys Laboratories INR 12.1B 2.27B Dec/2025
Guangzhou Baiy CNY 793.91M 99.08M Sep/2025
Jiangsu Hengrui CNY 1.3B 1.27B Sep/2025
Kalbe Farma IDR 656.41B 241.76B Sep/2025
Richter Gedeon HUF 43.35B 6.29B Sep/2025
Sh Fosun Pharma CNY 821.33M 115.88M Sep/2025
Sun Pharmaceuticals INR 33.69B 2.51B Dec/2025
Teva Pharmaceutical Industries USD 480M 47M Dec/2025